Last reviewed · How we verify

NCT02543723

Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence

Completed NA Results posted Last updated 22 July 2021
What this trial tests

NA trial testing Nurse Coach Intervention in Medication Adherence in 128 participants. Completed in 31 December 2020.

Timeline
15 November 2015
Primary endpoint
30 March 2020
31 December 2020

Quick facts

Lead sponsorEast Carolina University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment128
Start date15 November 2015
Primary completion30 March 2020
Estimated completion31 December 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

East Carolina University

Who can join

18 and older, any sex, with Medication Adherence. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Medication Adherence at Baseline and 6-month Follow-up Period Primary · Baseline and at 6 months

The participant's cancer medication adherence was taken at baseline and within a 6-month follow-up period. We measured the participant's self-efficacy with medication adherence increase with their OCAs using the SEAMS scale. SEAMS Scale: 21 items scale, ranges from 21-63, higher scores indicate higher level of self-efficacy for medication adherence.

GroupValue95% CI
Nurse Coach Intervention59.4± 5.18
Control55.95± 9.34
Health Literacy at Baseline and 6-month Follow-up Period Secondary · Baseline and at 6 months

We measured the participant's cancer health literacy at baseline and at 6 months via the CHLT-30. The CHLT-30 measures cancer health literacy along a continuum with 0-30 representing the number of correct answers provided to the items. Continuous scores provided by the CHLT-30 do not allow to determine who has limited health literacy or put people in a category, with higher scores indicating a higher degree of cancer health literacy.

GroupValue95% CI
Nurse Coach Intervention22.95± 4.62
Control23.32± 8.36

Sponsor's own description

Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Telemedicine and the assessment of clinician time: a scoping review.
    Kidholm K, Jensen LK, Johansson M, Montori VM. · · 2023 · cited 16× · PMID 38099431 · DOI 10.1017/s0266462323002830

Verify or expand the search:

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

Other East Carolina University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02543723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing